ACADIA Pharmaceuticals Inc. vs Cenovus Energy Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Cenovus Energy Inc trades at $29.3 (market cap $55.00B). The key difference: Cenovus Energy Inc is far larger — about 10.8× ACADIA Pharmaceuticals Inc.'s market cap, and Cenovus Energy Inc pays a 2.09% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | CVE | |
|---|---|---|
Market Cap | $5.07B | $55.00B |
Sector | Health | Energy |
52-Week High | $29.41 | $31.80 |
52-Week Low | $20.06 | $14.83 |
Enterprise Value | $4.19B | $61.08B |
Dividend Yield | — | 2.09% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →